Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

An Open Label Extension of the LAQ/5062 and LAQ/5063 Studies to Assess the Long Term Safety and Tolerability of Laquinimod 0.6mg in RRMS Patients
Disease Modifying Potential of Glatiramer Acetate in Huntington's Disease.
Peripheral accumulation of newly produced T and B lymphocytes in natalizumab-treated multiple sclerosis patients.
First-line natalizumab in multiple sclerosis: rationale, patient selection, benefits and risks.
The therapeutic potential of mesenchymal stem cell transplantation as a treatment for multiple sclerosis: consensus report of the International MSCT Study Group.
Effectiveness of Natalizumab in Patients with Highly Active Relapsing Remitting Multiple Sclerosis.
Suppression of Murine Experimental Autoimmune Optic Neuritis by Mature Dendritic Cells Transfected with Calcitonin Gene-Related Peptide Gene.
Validation of a Dutch version of the Neurological Fatigue Index (NFI-MS) for patients with multiple sclerosis in the Netherlands.
The Effect of Three Times a Week Glatiramer Acetate on Cerebral T1 Hypointense Lesions in Relapsing-Remitting Multiple Sclerosis.
Treatment of multiple sclerosis with anti-CD20 antibodies.
Synthon announces successful outcome of the Phase III GATE study with its generic glatiramer acetate
Natural History of Multiple Sclerosis Symptoms
Genmab announces details of planned ofatumumab Phase II study in multiple sclerosis
Myasthenia gravis and neuromyelitis optica spectrum disorder: A multicenter study of 16 patients.
Pfizer and Synthon Enter Into U.S. Commercialization Agreement for Potential Generic Treatment of Multiple Sclerosis
Increased axonal expression of nectin-1 in multiple sclerosis plaques.
Serological evidence of increased susceptibility to varicella-zoster virus reactivation or reinfection in natalizumab-treated patients with multiple sclerosis.
Retrospective US database analysis of persistence with glatiramer acetate vs. available disease-modifying therapies for multiple sclerosis: 2001-2010.
Interference with RhoA-ROCK Signaling Mechanism in Autoreactive CD4(+) T Cells Enhances the Bioavailability of 1,25-Dihydroxyvitamin D(3) in Experimental Autoimmune Encephalomyelitis.
Treatment of multiple sclerosis with cyclophosphamide: critical review of clinical and immunologic effects.
Generic Midamor
Inhibition of glycerophosphate-dependent H2O2 generation in brown fat mitochondria by idebenone.
A practical review of the neuropathology and neuroimaging of multiple sclerosis.
Cutaneous and pulmonary sarcoidosis following treatment of multiple sclerosis with interferon-beta-1b: a case report.
B-cell depletion in vitro and in vivo with an afucosylated anti-CD19 antibody.

Pages